For the Inventor, By the Inventor

Enter assignee name

Princeton, NJ, United States of America

Cytogen Corporation

Calculating rank

USPTO Granted Patents = 34

% Expired Patents = 5.9

CIPO Patents = 5

EPO Patents = 3

Trademarks = 4

Forward Citations = 2,229

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Daniel J Coughlin (15 out of 19 patents)

Vernon L Alvarez (14 out of 17 patents)

Benjamin A Belinka, Jr (10 out of 14 patents)

4. John D Rodwell (9 out of 11 patents)

5. Thomas J McKearn (6 out of 8 patents)

6. Richard Wood (5 out of 5 patents)

7. Dana M Fowlkes (3 out of 30 patents)

8. Brian K Kay (3 out of 19 patents)

9. Byung Hee Jeon (3 out of 7 patents)

10. Robert D Radcliffe (3 out of 3 patents)

11. Julius S Horoszewicz (3 out of 3 patents)

12. Chyi Lee (3 out of 3 patents)

13. John W Goers (3 out of 3 patents)

14. Imelda Lambkin (2 out of 10 patents)

15. Gregorio Pirozzi (2 out of 2 patents)

Core Competencies:

Prostate Cancer

Polypeptides

Monoclonal Antibodies

Antigen Binding Peptides

Gene Mutation Analysis

Therapeutic Agents

Molecular Recognition

Peptide Libraries

Metal-Binding Constructs

Hybridooma

Aminophosphonic Acids

Site Specific Labeling

34 patents: Sort by Forward Citations

1. 11789023 - Androgen receptor variant-based prostate cancer patient screening method (2023-10-17),

2. 11718882 - EML4-ALK gene mutation analysis method (2023-08-08),

3. 11513124 - Prostate-specific membrane antigen-based prostate cancer patient screening method (2022-11-29),

4. 7279548 - Identification and isolation of novel polypeptides having WW domains and methods of using same (2007-10-09),

5. 7223547 - Polypeptides having a functional domain of interest and methods of identifying and using same (2007-05-29),

6. 7135457 - Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods (2006-11-14),

7. 7053177 - Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods (2006-05-30),

8. 6015561 - Antigen binding peptides (abtides) from peptide libraries (2000-01-18),

9. 6011137 - Identification and isolation of novel polypeptides having WW domains and (2000-01-04),

10. 5942210 - Methods for lyoprotecting a macromolecule using tricine (1999-08-24),

11. 5885577 - Antigen binding peptides (abtides) from peptide libraries (1999-03-23),

12. 5763202 - Methods of detecting prostate carcinoma using a monoclonal antibody to a (1998-06-09),

13. 5609847 - Treatment methods using metal-binding targeted polypeptide constructs (1997-03-11),

14. 5593656 - Metal-binding targeted polypeptide constructs (1997-01-14),

15. 5585468 - Substituted thioureas as bifunctional chelators (1996-12-17),

Company Overview

Cytogen Corporation is a biotechnology firm based in Princeton, NJ, specializing in the development of innovative therapies for cancer treatment. The company focuses on harnessing advanced technologies in molecular biology and genomics to create targeted therapies that improve patient outcomes. With a commitment to research and development, Cytogen aims to address unmet medical needs in oncology, leveraging its expertise to advance the field of precision medicine and enhance therapeutic options for patients.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

34 Patents

#36 in Princeton, NJ

#404 in New Jersey

#10,022 in US

#19,651 in the World

Princeton, NJ, United States of America

Cytogen Corporation

Forward Citations = 2,229

31 inventors:

Daniel J Coughlin (15 out of 19 patents)

Vernon L Alvarez (14 out of 17 patents)

Benjamin A Belinka, Jr (10 out of 14 patents)

4. John D Rodwell (9 out of 11 patents)

5. Thomas J McKearn (6 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cytogen Corporation. Retrieved from https://idiyas.com/company/cytogen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…